Acarbose

Alpha-Glucosidase Inhibitor — Diabetes

• Drug Class: Alpha-Glucosidase Inhibitor
• Category: Diabetes
• Type: Small Molecule
• SMILES: OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O2)OC(CO)[C@H]1O

What is Acarbose?

Acarbose is an oral medication primarily used to manage type 2 diabetes mellitus. It belongs to a class of drugs known as alpha-glucosidase inhibitors. These medications work by slowing down the digestion and absorption of carbohydrates in the small intestine, thereby helping to reduce the spike in blood glucose levels that typically occurs after eating. Acarbose is available as a generic medication and is also marketed under brand names such as Precose. It is often prescribed as an adjunct therapy to diet and exercise, and sometimes in combination with other diabetes medications, to achieve better glycemic control.

Mechanism of Action

Acarbose exerts its therapeutic effect by competitively inhibiting the activity of alpha-glucosidase enzymes located in the brush border of the small intestine. These enzymes, including sucrase, maltase, isomaltase, and glucoamylase, are responsible for breaking down complex carbohydrates (like starches and disaccharides) into simpler monosaccharides (such as glucose) that can be absorbed into the bloodstream. By inhibiting these enzymes, acarbose effectively delays the hydrolysis of ingested carbohydrates. This delay leads to a slower and more gradual absorption of glucose into the systemic circulation following a meal, which in turn helps to blunt the postprandial rise in blood glucose levels. The molecular structure of acarbose mimics that of its natural substrates, allowing it to bind to the active sites of these enzymes, thereby preventing them from performing their catalytic function. This targeted action specifically addresses postprandial hyperglycemia, a significant contributor to overall glycemic burden in individuals with type 2 diabetes.

Clinical Uses & Indications

The primary indication for acarbose is the management of type 2 diabetes mellitus, particularly in patients whose blood glucose levels are inadequately controlled by diet and exercise alone. It is most effective in reducing postprandial hyperglycemia, the sharp increase in blood sugar levels that occurs after meals. The U.S. Food and Drug Administration (FDA) has approved acarbose for this indication. It can be used as monotherapy or in combination with other oral antidiabetic agents, such as metformin or sulfonylureas, or with insulin therapy. Its role is to improve overall glycemic control, as measured by HbA1c levels. While not a cure for diabetes, acarbose is a valuable tool in a comprehensive management plan aimed at reducing the risk of long-term diabetes-related complications, such as cardiovascular disease, nephropathy, retinopathy, and neuropathy.

Dosage & Administration

Acarbose is administered orally, typically three times a day, with the first bite of each main meal. This timing is crucial for its efficacy, as it needs to be present in the intestine to inhibit carbohydrate digestion as food is consumed. The starting dose for acarbose is usually low, often 25 mg three times daily, to allow the body to adapt and minimize gastrointestinal side effects. The dose is then gradually increased based on the patient's glycemic response and tolerance. Typical maintenance doses range from 50 mg to 100 mg three times daily. The maximum recommended daily dose is 100 mg three times daily (totaling 300 mg per day). It is essential that patients continue to adhere to their prescribed diet and exercise regimen while taking acarbose, as the medication's effectiveness is dependent on these lifestyle modifications.

Common Dosage Forms:

• Tablets: Available in strengths of 25 mg, 50 mg, and 100 mg.

Administration Guidelines:

• Take with the first bite of each main meal.
• Swallow whole with water; do not chew or crush.
• Individualize dosage based on glycemic response and tolerance.
• Monitor blood glucose levels regularly.

Side Effects & Safety

The most common side effects associated with acarbose are gastrointestinal in nature, stemming from its mechanism of action. As undigested carbohydrates reach the colon, they are fermented by bacteria, leading to increased gas production. This can manifest as:

• Flatulence (gas): This is the most frequently reported side effect.
• Diarrhea: Can occur due to the osmotic effect of undigested carbohydrates and fermentation products.
• Abdominal pain or discomfort: Often related to bloating and gas.

These side effects are dose-dependent and often diminish over time as the body adjusts. However, they can sometimes be severe enough to lead to discontinuation of the medication. Patients should be advised to report any persistent or bothersome side effects to their healthcare provider.

Serious Side Effects:

While rare, more serious side effects can occur:

• Hepatotoxicity: There have been rare reports of liver enzyme elevations and, in very rare cases, liver failure. Regular monitoring of liver function tests may be recommended, especially with long-term use or higher doses.
• Hypoglycemia: Acarbose itself does not typically cause hypoglycemia when used alone, as it only affects postprandial glucose. However, if used in combination with other glucose-lowering agents like sulfonylureas or insulin, the risk of hypoglycemia is increased. If hypoglycemia occurs, it should be treated with glucose (dextrose), not sucrose (table sugar), as acarbose inhibits the breakdown of sucrose.

Contraindications:

Acarbose is contraindicated in patients with:

• Known hypersensitivity to acarbose or any component of the formulation.
• Diabetic ketoacidosis.
• Intestinal obstruction or conditions that would predispose to intestinal obstruction.
• Individuals with significant gastrointestinal diseases such as inflammatory bowel disease, colonic ulceration, or intestinal obstruction.

Drug Interactions

Acarbose can interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Key interactions include:

• Other Antidiabetic Agents: When used concurrently with sulfonylureas, metformin, or insulin, there is an increased risk of hypoglycemia. Close monitoring of blood glucose levels and potential dose adjustments of the other agents may be necessary.
• Digestive Enzyme Supplements: Medications containing amylase or pancreatin may reduce the effectiveness of acarbose by breaking down carbohydrates before acarbose can act.
• Cholestyramine: This bile acid sequestrant may interfere with the absorption of acarbose.
• Activated Charcoal: This substance can adsorb acarbose, reducing its absorption and efficacy.
• Sucrose and other complex carbohydrates: As mentioned, acarbose inhibits the breakdown of sucrose. Therefore, ingestion of sucrose during an episode of hypoglycemia while taking acarbose will not effectively raise blood glucose levels and may worsen gastrointestinal symptoms. Patients should be advised to treat hypoglycemia with glucose (dextrose) tablets or gel.

Molecular Properties

Acarbose is a complex molecule that functions as an inhibitor of carbohydrate-digesting enzymes. Its chemical structure is key to its pharmacological activity.

Key Molecular Information:

• Molecular Formula: C₂₅H₄₃NO₁₉
• Molecular Weight: Approximately 637.63 g/mol
• Structure Description: Acarbose is a pseudotetrasaccharide. It is an inhibitor of oligosaccharidases, including sucrase, isomaltase, maltase, and glucoamylase. Its structure consists of a glucose moiety linked to a valienamine derivative, which is further linked to two additional glucose units. This complex carbohydrate-like structure allows it to bind to the active sites of alpha-glucosidase enzymes.
• SMILES Notation: OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O2)OC(CO)[C@H]1O

The SMILES (Simplified Molecular Input Line Entry System) string, OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O2)OC(CO)[C@H]1O, provides a linear representation of the molecule's structure, detailing the connectivity and stereochemistry of its atoms. This notation is crucial for computational analysis, database searching, and molecular modeling.

Analyze Acarbose with MolForge

Understanding the intricate molecular properties and potential interactions of drugs like acarbose is fundamental to advancing pharmaceutical research and development. MolForge offers a powerful AI-driven platform designed to accelerate molecular discovery and analysis. By leveraging cutting-edge artificial intelligence, MolForge enables researchers to explore drug candidates, predict their properties, and identify potential therapeutic targets with unprecedented speed and accuracy. Discover how MolForge can assist in dissecting complex molecules, predicting ADMET properties, and optimizing drug design. Explore the future of pharmaceutical innovation by visiting our dashboard today and see how AI can transform your research.